Inventor · disambiguated record
Shendong Yuan
Also filed as: YUAN SHENDONG
28 granted patents·23 pending applications·100 citations·filing 2002–2023
94Inventor score
Files withSCHERING AG8BLADE THERAPEUTICS INC7ZOMAGEN BIOSCIENCES LTD7VENTYX BIOSCIENCES INC6ESCALIER BIOSCIENCES B V4
Top patents by PatentIndex Score
51 records- 0194US10934261B2Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2017·Granted Mar 2, 2021·15 cites·44 claims
- 0294US10590084B2Cyclic keto-amide compounds as calpain modulators and methods of production and use thereofBLADE THERAPEUTICS INC·Filed 2017·Granted Mar 17, 2020·20 cites·19 claims
- 0390US6861424B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2002·Granted Mar 1, 2005·19 cites·60 claims
- 0484US8367836B2Pyridinone antagonists of alpha-4 integrinsELAN PHARM INC·Filed 2010·Granted Feb 5, 2013·8 cites·27 claims
- 0582US7026323B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2004·Granted Apr 11, 2006·8 cites·7 claims
- 0680US11753411B2Substituted pyrazolo[1,5-a]pyrimidines as TYK2 pseudokinase ligandsVENTYX BIOSCIENCES INC·Filed 2020·Granted Sep 12, 2023·1 cites·19 claims
- 0778US7504410B2Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agentsSCHERING AG·Filed 2003·Granted Mar 17, 2009·13 cites·22 claims
- 0876US2024101571A1Nlrp3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 0974US7105563B2Indolinone derivatives and their use in treating disease-states such as cancerSCHERING AG·Filed 2004·Granted Sep 12, 2006·10 cites·15 claims
- 1073US2023183258A1Nlrp3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 1171US2022324814A1Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1270US2023406858A1Tyk2 pseudokinase ligandsVENTYX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1369US2023348478A1Tyk2 pseudokinase ligandsVENTYX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1467US8198456B2Dihydropyridine derivatives as useful as protein kinase inhibitorsADLER MARC·Filed 2007·Granted Jun 12, 2012·2 cites·10 claims
- 1567US6995156B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2004·Granted Feb 7, 2006·2 cites·20 claims
- 1667US2023312589A1Jak inhibitorsVIMALAN BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 1766US11603375B2NLRP3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2021·Granted Mar 14, 2023·0 cites·20 claims
- 1866US11339130B1Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2020·Granted May 24, 2022·0 cites·46 claims
- 1963US2015087826A1Spirocyclic digydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereofXU YING-ZI·Filed 2014·Application pending·0 cites
- 2063US2015087825A1Spirocyclic digydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereofXU YING-ZI·Filed 2014·Application pending·0 cites
- 2162US8008325B2Plasma carboxypeptidase B inhibitorsBAYER SCHERING PHARMA AG·Filed 2008·Granted Aug 30, 2011·0 cites·14 claims
- 2262US7528173B2Plasma carboxypeptidase B inhibitorsSCHERING AKTIENGESELLSHAFT·Filed 2003·Granted May 5, 2009·2 cites·16 claims
- 2362US2022106329A1Bicyclic ror-gamma modulatorsESCALIER BIOSCIENCES B V·Filed 2021·Application pending·0 cites
- 2462US2022106323A1Spirocyclic ror-gamma modulatorsESCALIER BIOSCIENCES B V·Filed 2021·Application pending·0 cites
- 2560US7176207B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2006·Granted Feb 13, 2007·0 cites·3 claims
- 2659US11242350B2Spirocyclic ROR-gamma modulatorsESCALIER BIOSCIENCES B V·Filed 2019·Granted Feb 8, 2022·0 cites·20 claims
- 2759US11230555B2Bicyclic RORγ modulatorsESCALIER BIOSCIENCES B V·Filed 2019·Granted Jan 25, 2022·0 cites·19 claims
- 2858US2024010649A1Crystalline forms of an s1p receptor modulatorOPPILAN PHARMA LTD·Filed 2023·Application pending·0 cites
- 2957US11780842B2TYK2 pseudokinase ligandsVENTYX BIOSCIENCES INC·Filed 2020·Granted Oct 10, 2023·0 cites·19 claims
- 3057US9493485B2Spirocyclic dihydro-thiazine and dihydro-oxazine BACE inhibitors, and compositions and uses thereofIMAGO PHARMACEUTICALS INC·Filed 2013·Granted Nov 15, 2016·0 cites·19 claims
- 3156US11459333B2Substituted pyrrolo[2,3-d]pyrimidines as JAK inhibitorsVIMALAN BIOSCIENCES INC·Filed 2020·Granted Oct 4, 2022·0 cites·20 claims
- 3255US2023295113A1Nlrp3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2023·Application pending·0 cites
- 3354US2024010654A1Crystalline forms of a tyk2 inhibitorVENTYX BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 3453US7084142B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2006·Granted Aug 1, 2006·0 cites·15 claims
- 3553US2016272654A1Spirocyclic dihydro-thiazine and dihydro-oxazine bace inhibitors, and compositions and uses thereofIMAGO PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3652US7056923B2Platelet adenosine diphosphate receptor antagonistsSCHERING AG·Filed 2003·Granted Jun 6, 2006·0 cites·16 claims
- 3752US2024327413A1Nlrp3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2022·Application pending·0 cites
- 3851US12466800B2N-((1,2,3,5,6,7-hexahydro-S-indacen-4-yl)carbamoyl)-4, 5, 6, 7-tetrahydrobenzofuran-2-sulfonamide derivatives and related compounds as NLPR3 modulators for the treatment of multiple sclerosis (MS)ZOMAGEN BIOSCIENCES LTD·Filed 2020·Granted Nov 11, 2025·0 cites·19 claims
- 3951US12351564B2NLRP3 modulatorsZOMAGEN BIOSCIENCES LTD·Filed 2020·Granted Jul 8, 2025·0 cites·20 claims
- 4049US11932606B2Anti-cancer/anti-fibrosis compoundsUNIV CALIFORNIA·Filed 2018·Granted Mar 19, 2024·0 cites·13 claims
- 4149US2013252957A1Pyridinone antagonists of alpha-4 integrinsELAN PHARM INC·Filed 2012·Application pending·0 cites
- 4249US2011319366A1Plasma Carboxypeptidase B InhibitorsBUCKMAN BRAD·Filed 2011·Application pending·0 cites
- 4348US2023024521A1Jak inhibitorsVIMALAN BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 4445US11136329B2JAK inhibitorsVIMALAN BIOSCIENCES INC·Filed 2020·Granted Oct 5, 2021·0 cites·19 claims
- 4544US2022135567A1Tyk2 pseudokinase ligandsVENTYX BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 4644US2021238192A1Vascular adhesion protein-1 (vap-1) modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4744US2014213538A1Lysophosphatidic acid receptor antagonistsINTERMUNE INC·Filed 2014·Application pending·0 cites
- 4844US2021009564A1Calpain modulators and therapeutic uses thereofBLADE THERAPERTICS INC·Filed 2019·Application pending·0 cites
- 4940US2021347727A1Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 5039US11292801B2Calpain modulators and therapeutic uses thereofBLADE THERAPEUTICS INC·Filed 2017·Granted Apr 5, 2022·0 cites·22 claims
Showing the top 50 of 51 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →